Drug
C HS 10504
C HS 10504: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| [¹⁴C]HS-10504 NCT07764705 | Phase 1 | Healthy Subjects |
Latest
No recent events.
Follow C HS 10504 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.